All Stories

  1. Crystal structure of Qa-1a with bound Qa-1 determinant modifier peptide
  2. Galactosylsphingamides: new α-GalCer analogues to probe the F’-pocket of CD1d
  3. Autoreactivity to Sulfatide by Human Invariant NKT Cells
  4. N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death
  5. Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01
  6. Antibody Recognition of Immunodominant Vaccinia Virus Envelope Proteins
  7. Structure of HLA-A2:01 with peptide Y16R
  8. Structure of HLA-A2:01 with peptide G11N
  9. Structure of HLA-A2:01 with peptide Y9L
  10. Structure of HLA-A2:01 with peptide Y10L
  11. Structure of HLA-A2:01 with peptide G13E
  12. Structure of HLA-A2:01 with peptide G9L
  13. Structure of HLA-A2:01 with the 12-mer peptide F12K
  14. The CD1 family: serving lipid antigens to T cells since the Mesozoic era
  15. Crystal structure of mouse CD1d in complex with the p99p lipopeptide
  16. Crystal structure of the mouse CD1d in complex with the p99 peptide
  17. Structure of an α-Helical Peptide and Lipopeptide Bound to the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule CD1d
  18. Structure of the murine Fab 1G6 bound to the vaccinia virus A27 peptide 31-40
  19. Structure of the murine antibody Fab 8E3 bound to the vaccinia virus A27 peptide 101-110
  20. Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox
  21. Toxoplasma gondiipeptide ligands open the gate of the HLA class I binding groove
  22. Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer
  23. Recognition of Microbial Glycolipids by Natural Killer T Cells
  24. Synthesis of C-5″ and C-6″-modified α-GalCer analogues as iNKT-cell agonists
  25. Crystal structure of the mCD1d/DB06-1/iNKTCR ternary complex
  26. A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-γ Production
  27. Crystal structure of the mCD1d/NC-aGC/iNKTCR ternary complex
  28. Crystal structure of the mCD1d/GCK152/iNKTCR ternary complex
  29. Crystal structure of the mCD1d/7DW8-5/iNKTCR ternary complex
  30. Crystal structure of the mCD1d/EF77/iNKTCR ternary complex
  31. Murine Anti-vaccinia Virus D8 Antibodies Target Different Epitopes and Differ in Their Ability to Block D8 Binding to CS-E
  32. The Identification of the Endogenous Ligands of Natural Killer T Cells Reveals the Presence of Mammalian α-Linked Glycosylceramides
  33. Structure of mouse CD1d in complex with dioleoyl-phosphatidic acid
  34. The Identification of the Endogenous Ligands of Natural Killer T Cells Reveals the Presence of Mammalian α-Linked Glycosylceramides
  35. Recognition of Lysophosphatidylcholine by Type II NKT Cells and Protection from an Inflammatory Liver Disease
  36. Vaccinia L1/M12B9-Fab complex
  37. Structure of murine IgG2b A2C7-Fab in complex with vaccinia antigen A33R at the resolution of 2.3 Angstroms
  38. Structure of murine IgG2a A27D7-Fab in complex with vaccinia antigen A33R at the resolution of 1.6 Angstroms
  39. Structure of murine IgG2a A20G2-Fab in complex with vaccinia antigen A33R at the resolution of 2.9 Angstroms
  40. Galectin-9 controls the therapeutic activity of 4-1BB–targeting antibodies
  41. Using a Combined Computational-Experimental Approach to Predict Antibody-Specific B Cell Epitopes
  42. Structure of Human Cytomegalovirus Immune Modulator UL141
  43. The structure of cytomegalovirus immune modulator UL141 highlights structural Ig-fold versatility for receptor binding
  44. Helicobacter pylori Cholesteryl α-Glucosides Contribute to Its Pathogenicity and Immune Response by Natural Killer T Cells
  45. A γδ T‐cell glimpse of glycolipids
  46. Structure of the mouse CD1d-PyrC-alpha-GalCer-iNKT TCR complex
  47. Structure of the mouse CD1d-4ClPhC-alpha-GalCer-iNKT TCR complex
  48. A 'GEM' of a cell
  49. Crystal structure of human cytomegalovirus glycoprotein UL141 targeting the death receptor TRAIL-R2
  50. Human Cytomegalovirus Glycoprotein UL141 Targets the TRAIL Death Receptors to Thwart Host Innate Antiviral Defenses
  51. Crystal structure of bovine CD1d with bound C12-di-sulfatide
  52. Crystal structure of bovine CD1d with bound C16:0-alpha-galactosyl ceramide
  53. Crystal Structures of Bovine CD1d Reveal Altered αGalCer Presentation and a Restricted A’ Pocket Unable to Bind Long-Chain Glycolipids
  54. Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells
  55. Phage display generation of a novel human anti-CD1A monoclonal antibody with potent cytolytic activity
  56. Crystal structure of the Hy19.3 type II NKT TCR
  57. Crystal structure of the mouse CD1d-lysosulfatide-Hy19.3 TCR complex
  58. Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens
  59. Vaccinia D8L ectodomain structure
  60. Fab structure of anti-Vaccinia virus D8L antigen mouse IgG2a LA5
  61. Vaccinia virus D8L IMV envelope protein in complex with Fab of murine IgG2a LA5
  62. Crystal structure of the LDL receptor tail in complex with autosomal recessive hypercholesterolemia PTB domain
  63. Structure of the mouse CD1d-HS44-iNKT TCR complex
  64. Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells
  65. Structure of the mouse CD1d-SMC124-iNKT TCR complex
  66. Histamine-releasing factor has a proinflammatory role in mouse models of asthma and allergy
  67. Glycolipids that Elicit IFN-γ-Biased Responses from Natural Killer T Cells
  68. Structure of the mouse CD1d-Glc-DAG-s2-iNKT TCR complex
  69. Structural Basis for the Recognition of C20:2-αGalCer by the Invariant Natural Killer T Cell Receptor-like Antibody L363
  70. Crystal structure of the mouse CD1d-C20:2-aGalCer-L363 mAb Fab complex
  71. Unique Interplay between Sugar and Lipid in Determining the Antigenic Potency of Bacterial Antigens for NKT Cells
  72. Crystal structure of the mouse CD1d-Glc-DAG-s2 complex
  73. Structure of the self-antigen iGb3 bound to mouse CD1d and in complex with the iNKT TCR
  74. Structure of the mouse CD1d-NU-alpha-GalCer-iNKT TCR complex
  75. Structure of the mouse CD1d-alpha-C-GalCer-iNKT TCR complex
  76. Structure of the mouse CD1d-BnNH-GSL-1'-iNKT TCR complex
  77. Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis
  78. Crystal structure of Cardiolipin bound to mouse CD1D
  79. Divergent synthetic approach to 6′′-modified α-GalCer analogues
  80. IEDB-3D: structural data within the immune epitope database
  81. The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode
  82. Recognition of Glycolipid Antigen by iNKT Cell TCR
  83. Recognition of a Glycolipid Antigen by the iNKT Cell TCR
  84. Synthesis and Evaluation of Amino-Modified α-GalCer Analogues
  85. Crystal structure of bovine CD1b3 with endogenously bound ligands
  86. Allosteric Regulation of the Ubiquitin:NIK and Ubiquitin:TRAF3 E3 Ligases by the Lymphotoxin-β Receptor
  87. Crystal Structure of chicken CD1-1
  88. Conservation of CD1 protein expression patterns in the chicken
  89. Structure of mCD1d with bound glycolipid BbGL-2c from Borrelia burgdorferi
  90. Structure of mCD1d with bound glycolipid BbGL-2f from Borrelia burgdorferi
  91. Structural Basis for Lipid-Antigen Recognition in Avian Immunity
  92. Optimizing the iNKT Cell Dependent Antitumor Effect Using an Altered Glycolipid
  93. Crystal structure of the alpha-galactosylceramide analog OCH in complex with mouse CD1d
  94. Mechanisms for Glycolipid Antigen-Driven Cytokine Polarization by Vα14 i NKT Cells
  95. Synthesis of Dideoxymycobactin Antigens Presented by CD1a Reveals T Cell Fine Specificity for Natural Lipopeptide Structures
  96. Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells
  97. Functional CD1d and/or NKT cell invariant chain transcript in horse, pig, African elephant and guinea pig, but not in ruminants
  98. Polyclonal IgE Induces Mast Cell Survival and Cytokine Production
  99. Structure of chicken CD1-2 with bound fatty acid
  100. pH-Dependent Interdomain Tethers of CD1b Regulate Its Antigen Capture
  101. Two canine CD1a proteins are differentially expressed in skin
  102. Crystal Structures of Mouse CD1d-iGb3 Complex and its Cognate Vα14 T Cell Receptor Suggest a Model for Dual Recognition of Foreign and Self Glycolipids
  103. Structure of the mouse invariant NKT cell receptor Valpha14
  104. Structure of the endogenous iNKT cell ligand iGb3 bound to mCD1d
  105. Mycobacterial lipoglycan presentation by CD1d
  106. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria
  107. Role of lipid trimming and CD1 groove size in cellular antigen presentation
  108. Structure of a microbial glycosphingolipid bound to mouse CD1d
  109. Structural basis of sulfatide presentation by mouse CD1d
  110. Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity
  111. Structure of a highly potent short-chain galactosyl ceramide agonist bound to CD1D
  112. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor
  113. T-cell activation by lipopeptide antigens
  114. Anatomy of CD1–lipid antigen complexes
  115. Crystal structure of CD1a in complex with a synthetic mycobactin lipopeptide
  116. CD1 assembly and the formation of CD1–antigen complexes
  117. Molecular Mechanism of Lipopeptide Presentation by CD1a
  118. Crystal Structure of CD1a in Complex with a Sulfatide
  119. Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 Å
  120. ISC1-encoded inositol phosphosphingolipid phospholipase C is involved in Na+/Li+ halotolerance of Saccharomyces cerevisiae
  121. Fatty acid elongation in yeast. Biochemical characteristics of the enzyme system and isolation of elongation-defective mutants
  122. Architecture of CD1 Proteins